 | • レポートコード：MRC2012A2645 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、デング熱ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。デング熱ワクチンの種類別市場規模（CYD-TDV、Tak-003、その他）、用途別市場規模（病院、政府機関、非政府組織（NGO））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Takeda Pharmaceutical、 ・地域別グローバル市場分析 2015年-2020年 ・デング熱ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・デング熱ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・デング熱ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・デング熱ワクチンの南米市場（ブラジル、アルゼンチン） ・デング熱ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：CYD-TDV、Tak-003、その他 ・用途別分析：病院、政府機関、非政府組織（NGO） ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Dengue Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 22.8% in the forecast period of 2020 to 2025 and will expected to reach USD 388.8 million by 2025, from USD 171 million in 2019.
The Dengue Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dengue Vaccines market has been segmented into
CYD-TDV
Tak-003
Other
By Application, Dengue Vaccines has been segmented into:
Hospitals
Government Institutes
Non-Governmental Organizations (NGOs)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dengue Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Dengue Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dengue Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Dengue Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dengue Vaccines Market Share Analysis
Dengue Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dengue Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dengue Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Dengue Vaccines are:
Sanofi
Takeda Pharmaceutical
Among other players domestic and global, Dengue Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dengue Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dengue Vaccines, with price, sales, revenue and global market share of Dengue Vaccines in 2018 and 2019.
Chapter 3, the Dengue Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dengue Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dengue Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dengue Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dengue Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dengue Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CYD-TDV
1.2.3 Tak-003
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Dengue Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Government Institutes
1.3.4 Non-Governmental Organizations (NGOs)
1.4 Overview of Global Dengue Vaccines Market
1.4.1 Global Dengue Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Dengue Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda Pharmaceutical
2.2.1 Takeda Pharmaceutical Details
2.2.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda Pharmaceutical SWOT Analysis
2.2.4 Takeda Pharmaceutical Product and Services
2.2.5 Takeda Pharmaceutical Dengue Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dengue Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dengue Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dengue Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Dengue Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dengue Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Dengue Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dengue Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Dengue Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Dengue Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dengue Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Dengue Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dengue Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dengue Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Dengue Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Dengue Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Dengue Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Dengue Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Dengue Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dengue Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Dengue Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dengue Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Dengue Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Dengue Vaccines Sales and Growth Rate (2015-2020)
6.4 France Dengue Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Dengue Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Dengue Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dengue Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dengue Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dengue Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Dengue Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Dengue Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Dengue Vaccines Sales and Growth Rate (2015-2020)
7.5 India Dengue Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dengue Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Dengue Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dengue Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Dengue Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Dengue Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dengue Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Dengue Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dengue Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dengue Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dengue Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dengue Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Dengue Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Dengue Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Dengue Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dengue Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Dengue Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Dengue Vaccines Price by Type (2015-2020)
11 Global Dengue Vaccines Market Segment by Application
11.1 Global Dengue Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Dengue Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Dengue Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dengue Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Dengue Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Dengue Vaccines Market Forecast (2021-2025)
12.2.2 Europe Dengue Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dengue Vaccines Market Forecast (2021-2025)
12.2.4 South America Dengue Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dengue Vaccines Market Forecast (2021-2025)
12.3 Dengue Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Dengue Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Dengue Vaccines Market Share Forecast by Type (2021-2025)
12.4 Dengue Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Dengue Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Dengue Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dengue Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dengue Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dengue Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Dengue Vaccines Major Business
Table 9. Sanofi Dengue Vaccines Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Dengue Vaccines Product and Services
Table 12. Sanofi Dengue Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Takeda Pharmaceutical Dengue Vaccines Major Business
Table 15. Takeda Pharmaceutical Dengue Vaccines Total Revenue (USD Million) (2017-2018)
Table 16. Takeda Pharmaceutical SWOT Analysis
Table 17. Takeda Pharmaceutical Dengue Vaccines Product and Services
Table 18. Takeda Pharmaceutical Dengue Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Dengue Vaccines Sales by Manufacturer (2018-2019) (K Dose)
Table 20. Global Dengue Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Dengue Vaccines Sales by Regions (2015-2020) (K Dose)
Table 22. Global Dengue Vaccines Sales Market Share by Regions (2015-2020)
Table 23. Global Dengue Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Dengue Vaccines Sales by Countries (2015-2020) (K Dose)
Table 25. North America Dengue Vaccines Sales Market Share by Countries (2015-2020)
Table 26. North America Dengue Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Table 28. Europe Dengue Vaccines Sales by Countries (2015-2020) (K Dose)
Table 29. Europe Dengue Vaccines Sales Market Share by Countries (2015-2020)
Table 30. Europe Dengue Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Dengue Vaccines Sales by Regions (2015-2020) (K Dose)
Table 32. Asia-Pacific Dengue Vaccines Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Dengue Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Dengue Vaccines Sales by Countries (2015-2020) (K Dose)
Table 35. South America Dengue Vaccines Sales Market Share by Countries (2015-2020)
Table 36. South America Dengue Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Dengue Vaccines Sales by Countries (2015-2020) (K Dose)
Table 39. Middle East & Africa Dengue Vaccines Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Dengue Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Table 42. Global Dengue Vaccines Sales by Type (2015-2020) (K Dose)
Table 43. Global Dengue Vaccines Sales Share by Type (2015-2020)
Table 44. Global Dengue Vaccines Revenue by Type (2015-2020) (USD Million)
Table 45. Global Dengue Vaccines Revenue Share by Type (2015-2020)
Table 46. Global Dengue Vaccines Sales by Application (2015-2020) (K Dose)
Table 47. Global Dengue Vaccines Sales Share by Application (2015-2020)
Table 48. Global Dengue Vaccines Sales Forecast by Regions (2021-2025) (K Dose)
Table 49. Global Dengue Vaccines Market Share Forecast by Regions (2021-2025)
Table 50. Global Dengue Vaccines Sales Forecast by Type (2021-2025) (K Dose)
Table 51. Global Dengue Vaccines Market Share Forecast by Type (2021-2025)
Table 52. Global Dengue Vaccines Sales Forecast by Application (2021-2025)
Table 53. Global Dengue Vaccines Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dengue Vaccines Picture
Figure 2. Global Sales Market Share of Dengue Vaccines by Type in 2019
Figure 3. CYD-TDV Picture
Figure 4. Tak-003 Picture
Figure 5. Other Picture
Figure 6. Dengue Vaccines Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Government Institutes Picture
Figure 9. Non-Governmental Organizations (NGOs) Picture
Figure 10. Global Dengue Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Dengue Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Dengue Vaccines Sales Market Share by Manufacturer in 2019
Figure 31. Global Dengue Vaccines Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Dengue Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Dengue Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 36. Global Dengue Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Dengue Vaccines Revenue Market Share by Regions (2015-2020)
Figure 38. Global Dengue Vaccines Revenue Market Share by Regions in 2018
Figure 39. North America Dengue Vaccines Sales and Growth Rate (2015-2020)
Figure 40. Europe Dengue Vaccines Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Dengue Vaccines Sales and Growth Rate (2015-2020)
Figure 42. South America Dengue Vaccines Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Dengue Vaccines Sales and Growth Rate (2015-2020)
Figure 44. North America Dengue Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Dengue Vaccines Sales Market Share by Countries (2015-2020)
Figure 46. North America Dengue Vaccines Sales Market Share by Countries in 2018
Figure 47. North America Dengue Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Dengue Vaccines Revenue Market Share by Countries in 2018
Figure 49. United States Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 50. Canada Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 51. Mexico Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 52. Europe Dengue Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Dengue Vaccines Revenue Market Share by Countries in 2019
Figure 55. Germany Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 56. UK Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 57. France Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 58. Russia Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 59. Italy Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 60. Asia-Pacific Dengue Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Dengue Vaccines Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Dengue Vaccines Revenue Market Share by Regions 2019
Figure 63. China Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 64. Japan Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 65. Korea Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 66. India Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 67. Southeast Asia Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 68. South America Dengue Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Dengue Vaccines Sales Market Share by Countries in 2019
Figure 70. South America Dengue Vaccines Revenue Market Share by Countries in 2019
Figure 71. Brazil Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 72. Argentina Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 73. Middle East and Africa Dengue Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Dengue Vaccines Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Dengue Vaccines Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Dengue Vaccines Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 78. Egypt Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 79. Turkey Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 80. South Africa Dengue Vaccines Sales and Growth Rate (2015-2020) (K Dose)
Figure 81. Global Dengue Vaccines Sales and Growth Rate (2021-2025) (K Dose)
Figure 82. Global Dengue Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Dengue Vaccines Market Forecast (2021-2025) (K Dose)
Figure 84. Europe Sales Dengue Vaccines Market Forecast (2021-2025) (K Dose)
Figure 85. Asia-Pacific Sales Dengue Vaccines Market Forecast (2021-2025) (K Dose)
Figure 86. South America Sales Dengue Vaccines Market Forecast (2021-2025) (K Dose)
Figure 87. Middle East & Africa Sales Dengue Vaccines Market Forecast (2021-2025) (K Dose)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
デング熱ワクチンの世界市場（～2026年） The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemo…- デング熱検査の世界市場（～2026年） The number of cases of dengue are growing rapidly during the past few years. Major regions of the world that are affected by dengue are Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific. As per the numbers provided by WHO, the number of reported cases is continu…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…